Upgrade Program | Tandem Diabetes Care

Our insulin pump and predictive technologies are designed to offer different approaches to managing diabetes based on the needs of the people using them.

The Tandem Diabetes Care Pump Access Program allows non-Tandem pump users with in-warranty pumps to upgrade to the t:slim X2 insulin pump and choose from either Control-IQ technology or Basal-IQ technology for the remainder of their current pump warranty.

Terms and Conditions

Why upgrade to the t:slim X2 insulin pump?

Helps Prevent Lows

Choose Basal-IQ technology, which can make diabetes management easier by predicting and helping to prevent lows with no routine fingersticks* when integrated with Dexcom G6 continuous glucose monitoring (CGM).^†

Helps Prevent Highs and Lows

Or choose Control-IQ technology, which can predict and help to prevent highs and lows with automatic insulin adjustments, correction boluses,^‡ and activity settings for sleep and exercise.

Program Eligibility

If you qualify, and for a one-time payment (see table), your new t:slim X2 insulin pump will remain under warranty with us for the duration of your previous pump’s warranty. To qualify for the program, you must:

Time Remaining in Warranty	Your Cost
2.5 years (or less)	$1,399
2.5 to 4 years	$1,899
More than 4 years	$2,899

Have at least six months of verifiable warranty remaining on your current insulin pump.

Cover the cost of supplies through your provincial program, private insurance, or out-of-pocket.

Not be eligible for a new pump through your provincial program or private plan.

Upgrade your pump!

THIS OPPORTUNITY EXPIRES June 30, 2024

Fill out your information and a Tandem representative will reach out to answer your questions and help you sign up for the Pump Access Program

First Name

Last Name

Email Address

Phone Number

Postal Code

What is the brand of your current insulin pump?

Consent

Responsible Use of Predictive Technologies

Systems like the t:slim X2 insulin pump with Basal-IQ technology and the t:slim X2 insulin pump with Control-IQ technology are not substitutes for active diabetes management. For example, users still must bolus for meals. Basal-IQ technology is designed to predict and help prevent lows, but it cannot prevent all lows and Basal-IQ technology does not predict high glucose events. Control-IQ technology is designed to predict and help prevent low and high glucose events, but it cannot prevent all highs and lows, and Control-IQ requires that users accurately input information, such as meals and periods of sleep or exercise. The Basal-IQ and Control-IQ features rely on continuous CGM readings and will not be able to predict glucose levels and adjust insulin dosing if your CGM is not working properly or is unable to communicate with your pump. Be sure to always use your pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Always pay attention to your symptoms, actively monitor your glucose levels, and treat according to your healthcare provider’s recommendations.

* No routine fingersticks required when using the t:slim X2 pump with Dexcom G6 continuous glucose monitoring (CGM) integration. If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
† CGM sold separately. The Dexcom transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 insulin pump) and one consumer device (phone or tablet) at the same time.
‡ If glucose values are predicted to be above 10.0 mmol/l, Control-IQ technology calculates a correction bolus using the personal profile settings and a target of 6.1 mmol/l and delivers 60% of that value.

Terms and Conditions
Tandem Diabetes Care Canada, Inc. (“Tandem”) offers eligible participants a t:slim X2 insulin pump with either Basal-IQ technology or Control-IQ technology (“Program Pump”) for an advance, one-time fee of $1,399 (2.5 years or less remaining in warranty), $1,899 (2.5 years to four years of remaining warranty), or $2,899 (more than four years of remaining warranty). Eligible participants will be entitled to use the Program Pump for the remainder of the warranty of participant’s current non-Tandem insulin pump (the “Program Period”).

Supplies can be purchased through Diabetes Express.

At the end of the Program Period, the Program Pump must be returned to Tandem within 30 days in the same condition in which it was received by participant (less reasonable wear and tear), or participant shall purchase the pump for $6,300, less the applicable program pump price.

During the time participant is authorized by Tandem to possess the Program Pump, it will be covered by Tandem’s standard warranty.

Confirmation of participant’s current warranty will be required to start the program. Tandem reserves the right to deny participation in the program in its sole discretion. This offer may be changed or discontinued at any time and will expire on June 30, 2024.

Important Safety Information

The pump and each System below is indicated for use in individuals 6 years of age and greater. The pump and each System is intended for single user use. The pump and each System is indicated for use with NovoRapid, Admelog, or Humalog U-100 insulin. This product may not be right for you. Always read and follow the label.

The t:slim X2 insulin pump with Basal-IQ technology (the Basal-IQ System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Basal-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings.

The t:slim X2 insulin pump with Control-IQ technology (the Control-IQ System) consists of the t:slim X2 insulin pump, which contains Control-IQ technology, and a compatible continuous glucose monitor (CGM, sold separately). The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the Control-IQ System. When used with a compatible CGM, the t:slim X2 insulin pump with Control-IQ technology can be used to automatically increase, decrease, and suspend delivery of basal insulin based on CGM sensor readings and predicted glucose values. The t:slim X2 insulin pump with Control-IQ technology can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The t:slim X2 insulin pump with Control-IQ technology is intended for the management of Type 1 diabetes.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in users who require less than 10 units of insulin per day or who weigh less than 25 kilograms.

Do not use the t:slim X2 insulin pump with Control-IQ technology if using hydroxyurea. Neither System is indicated for use in pregnant women, people on dialysis, or critically ill users. Users of the pump and either System must: be willing and able to use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit www.tandemdiabetes.com/safetyinfo for additional important safety information.

Tandem Benefit ProgramAn Easy Choice Made Easier

Why upgrade to the t:slim X2 insulin pump?

Program Eligibility

Upgrade your pump!

THIS OPPORTUNITY EXPIRES June 30, 2024

Resources & Support

About Tandem

Disclosures